ALEX PHARMACHEM PRIVATE LIMITED
About ALEX PHARMACHEM PRIVATE LIMITED
Certifications
Categories
-
Country/Region:India
-
On CPHI since:2022
-
Certificates:3
-
Employees:100 - 249
Company types
Primary activities
Meet us at
CPHI India 2026
IICC, Yashobhoomi, Dwarka, Delhi
23 Nov 2026 - 25 Nov 2026
Products from ALEX PHARMACHEM PRIVATE LIMITED (4)
-
Product Chlorhexidine Base
Chlorhexidine base is a intermediate and produce in a dedicated plant with annual capacity of 600 MT for Export, Domestic sale and captive use for the production of our high quality products such as Chlorhexidine Gluconate 20% Solution, Chlorhexidine HCl and Chlorhexidine Acetate.
-
Product Chlorhexidine Gluconate 20% Solution
Chlorhexidine Gluconate Solution 20% is produce in a dedicated plant with annual capacity of 3200 MT for Export & Domestic sale.
Chlorhexidine Gluconate 20% Solution is an salt of chlorhexidine which is broad spectrum bacteriostatic antiseptic agent, oral care agent, disinfectan... -
Product Lidocaine Base / HCL
Lidocaine Base is a free base local anesthetic and antiarrhythmic drug used to prevent and treat pain during surgical or diagnostic procedures. It is also used for the treatment of cardiac arrhythmias. Lidocaine can be administered orally, in topical applications or as a solution for injection.
Li... -
Product Lidocaine Hydrochloride
Lidocaine hydrochloride is salt form of Lidocaine which is local anaesthetic that works by blocking sodium channels in nerve cells, preventing them from firing and causing pain signals to be transmitted. It's also used as an antiarrhythmic agent to treat irregular heartbeats by decreasing the flow ...
ALEX PHARMACHEM PRIVATE LIMITED Resources (1)
-
Brochure Company Profile with Product List
Alex Pharmachem Pvt. Ltd. is a Manufacturer & Exporter of Bulk Drugs (API) & Intermediates, since 2000. Our manufacturing plant is WHO-GMP, FDA, WC, ISO, HALAL Certified, and we hold DMFs for all our products. We specialize in the manufacture of Chlorhexidine and its Salts, Lidocaine and Cetrimide.



